Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99363835 | 9936383 | 5 | F | 2012 | 20160729 | 20140228 | 20160803 | PER | US-AMGEN-USASP2014002581 | AMGEN | 74.00 | YR | E | F | Y | 0.00000 | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99363835 | 9936383 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, 2 TIMES/WK | 1065296 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | BIW | |||||
| 99363835 | 9936383 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 99363835 | 9936383 | 1 | Psoriasis |
| 99363835 | 9936383 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 99363835 | 9936383 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 99363835 | 9936383 | Drug effect decreased | |
| 99363835 | 9936383 | Injection site pain | |
| 99363835 | 9936383 | Kidney infection | |
| 99363835 | 9936383 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 99363835 | 9936383 | 1 | 20021231 | 20160728 | 0 |